Health Boards
Fri-24-02-2017, 13:39 PM
Some more clarity on the subject of DMF in the form of combination preparation with MEF and DMF.
Nicolle Litjens, is writing in her thesis on page 14: “Monomethylfumarate (MMF) is considered the most active metabolite and is formed in the circulation following the hydrolysis of DMF”. As can be seen under this sentence a schema is following, which shows what hydrolysis means (if you did not know that): and that is that a methyl group (CH3) is replaced by a hydrogen molecule (H).
![[Image: 33056014675_fd87882b3e_h.jpg]](https://c1.staticflickr.com/3/2681/33056014675_fd87882b3e_h.jpg)
Everyone who has passed a high school with a little chemistry can conclude from the picture, that from MonoEthylFumarate you can never form MonoMethylFumarate (MMF). Leading doctors, any doctor/dermatologist, should know that, together with the knowledge that the real working factor is MMF, this is the effective molecule. Still doctors are prescribing the combination preparation, of which one component not only does not have any anti-psoriasis effect, but even appears to be toxic.
In the Netherlands this would mean that a even a comparison between the two preparations is senseless as the difference so easily can be seen.
Litjens consciously has examined if there was a difference in activity between the several forms of fumarates concerning their influence on the citric acid cycle. DMF, MMF and MEF were compared. The effect of MEF appeared to be negligible (last line on page 20).
![[Image: 33014530946_61d2a20558_b.jpg]](https://c1.staticflickr.com/3/2842/33014530946_61d2a20558_b.jpg)
In the rest of the thesis MEF does not play a role anymore. Statements 2 and 3 belonging to the thesis, do speak a clear language (unfortunately I don’t have them). MMF is the most active metabolite (and this can only be originated from DMF). Litjens has written a thesis called: "Immunomodulatory effect of fumarates in psoriasis", and did for this thesis quite some practical research and a lot of theoretical research.
In the mean time science has progressed. The immediate reaction after the reading of the thesis of Litjens would be to prescribe MMF. Unfortunately the law in the Netherlands (after Psorinovo had hit the market) has changed in such a way that it is virtually impossible to get MMF on the market.
The requirements that must be fulfilled for new medicines have been raised so enormously that the development of a new medicine costs billions and that development only is admitted if the research protocol follows a strict and extremely expensive route (Once again people who know nothing block the quality of life of lots of their fellow civilians, only in the sake of utter safety and money). This route can only be followed by a multi national and if the stuff is patentable. MMF is not patentable. So it will only be done if there somehow is a large financial reward. The chance is there, because DMF (in reality MMF) can be used for more and more purposes.
Because what is happening…..:
Dr. B. Thomas, neuroscientists of the Department of Pharmacology and Toxicology and connected to the Medical College of Georgia (Augusta university) US, has published studies in the Journal of Neuroscience, which show that MMF and DMF stimulate the functioning of the mitochondria (the energy suppliers in every cell [we knew that already, read my thread]), but it appears that DMF initially slows down the working of the mitochondria for a short time, and only in second instance will stimulate, while MMF immediately stimulates the mitochondria.
This inconvenient and disadvantageous difference exists because DMF firstly retracts glutathione (an important anti oxidant) from the mitochondria. So they are working less efficiently and this explains according to dr. Thomas the unwanted side effects of DMF, that are not to be expected with MMF.
After the change of DMF into MMF, the so called hydrolysis, this disadvantage is again compensated and more than that. But this the explanation of the superiority of MMF as a medicine, which also were found by Litjens, without knowing the details.
By the way it is this essential effect on the mitochondria, which results in the fact that the body temperature is slightly rising and that people can get a red head (the well know flush), a point that dermatologists never mention, let it even be that they explain the effect on the cytric acid cycle, the biochemical proces that facilitates the production of energy in the mitochondria.
The role of the citric acid cycle I have earlier described in my thread Dimethylfumarates and Psoriasis, which is based on an article in the Dutch Magazine of Integral Medicine and written by my doctor.
The observed side effects of MEF (a possible detoriation of the kidney function) is based on the same disadvantage that DMF has to a much lesser extent, that is the negative influence on the mitochondria. It is well known that damaging the mitochondrial function in the first place influences the heart, but in the second place the kidneys. This follows in that chronic kidney diseases are mainly based on damaged mitochondria. This is the reason that chronic kidney diseases nowadays are treated with anti oxidants, for example Cysteine ( Bill ! ) , glutamine and glycine (J Nephrol 2015;42:318-319). MMF seen from this point could be a miracle medicine against heart muscle degradation and kidney degradation, but… also MMF has its lesser sides as it remains immunosuppressive.
By the way, the unwanted side effects of DMF (damaging the mitochondria) can be prevented by eating glutathione rich food and to avoid food with a lot of oxidants. Glutathion is available in raw vegetables and fruit, e.g. Asparagus, avocado and walnuts, fish and meat. You could also use a food supplement wich supplies you with glutathione 250-750 mg per day, depending on your DMF dose.
Schweckendiek prescibed (1981) with the use of fumarates, the anti oxidants cystine and glycine and extensively discussed the mitochondrial functioning in combination with the fumarate treatment.
It can be assumed that the dermatologists are too less aware of what is happening in the body. They may be too busy with the outside. The doctors who show the relation between psoriasis, mitochondria, the citric acid cycle and nutrition are not taken seriously.
The dermatologists are not aware what is happening and keep tight to therapies with MEF included. We do not know the effects of the biologicals on the mitochondria yet, but lets not be too negative on that. There is no research findable on that subject.
While neuro scientists have observed that MMF reduces the damage to the neurons with diseases as MS, Parkinson and other neurodegenerative diseases, in England a RCT has been started with Parkinson patients. The purpose is to stop the progress of this disease by this approach, the past has shown that giving anti oxidants to Parkinson patients is of no use.
We must be aware that the use of immunosuppressive medication increases the chance of dangerous infections, although we have seen in the last more than 30 years that this chance is low with the use of fumarates.
If you would want to lower your microbial “load” in order to reduce other immunosuppressive medication than there is another solution for that.
Literature.
Metabolite of oral DMF drug for multiple sclerosis appears to slow onset of Parkinson's disease; Medical Science News, June 9, 2016
Nicolle Litjens, is writing in her thesis on page 14: “Monomethylfumarate (MMF) is considered the most active metabolite and is formed in the circulation following the hydrolysis of DMF”. As can be seen under this sentence a schema is following, which shows what hydrolysis means (if you did not know that): and that is that a methyl group (CH3) is replaced by a hydrogen molecule (H).
Everyone who has passed a high school with a little chemistry can conclude from the picture, that from MonoEthylFumarate you can never form MonoMethylFumarate (MMF). Leading doctors, any doctor/dermatologist, should know that, together with the knowledge that the real working factor is MMF, this is the effective molecule. Still doctors are prescribing the combination preparation, of which one component not only does not have any anti-psoriasis effect, but even appears to be toxic.
In the Netherlands this would mean that a even a comparison between the two preparations is senseless as the difference so easily can be seen.
Litjens consciously has examined if there was a difference in activity between the several forms of fumarates concerning their influence on the citric acid cycle. DMF, MMF and MEF were compared. The effect of MEF appeared to be negligible (last line on page 20).
In the rest of the thesis MEF does not play a role anymore. Statements 2 and 3 belonging to the thesis, do speak a clear language (unfortunately I don’t have them). MMF is the most active metabolite (and this can only be originated from DMF). Litjens has written a thesis called: "Immunomodulatory effect of fumarates in psoriasis", and did for this thesis quite some practical research and a lot of theoretical research.
In the mean time science has progressed. The immediate reaction after the reading of the thesis of Litjens would be to prescribe MMF. Unfortunately the law in the Netherlands (after Psorinovo had hit the market) has changed in such a way that it is virtually impossible to get MMF on the market.
The requirements that must be fulfilled for new medicines have been raised so enormously that the development of a new medicine costs billions and that development only is admitted if the research protocol follows a strict and extremely expensive route (Once again people who know nothing block the quality of life of lots of their fellow civilians, only in the sake of utter safety and money). This route can only be followed by a multi national and if the stuff is patentable. MMF is not patentable. So it will only be done if there somehow is a large financial reward. The chance is there, because DMF (in reality MMF) can be used for more and more purposes.
Because what is happening…..:
Dr. B. Thomas, neuroscientists of the Department of Pharmacology and Toxicology and connected to the Medical College of Georgia (Augusta university) US, has published studies in the Journal of Neuroscience, which show that MMF and DMF stimulate the functioning of the mitochondria (the energy suppliers in every cell [we knew that already, read my thread]), but it appears that DMF initially slows down the working of the mitochondria for a short time, and only in second instance will stimulate, while MMF immediately stimulates the mitochondria.
This inconvenient and disadvantageous difference exists because DMF firstly retracts glutathione (an important anti oxidant) from the mitochondria. So they are working less efficiently and this explains according to dr. Thomas the unwanted side effects of DMF, that are not to be expected with MMF.
After the change of DMF into MMF, the so called hydrolysis, this disadvantage is again compensated and more than that. But this the explanation of the superiority of MMF as a medicine, which also were found by Litjens, without knowing the details.
By the way it is this essential effect on the mitochondria, which results in the fact that the body temperature is slightly rising and that people can get a red head (the well know flush), a point that dermatologists never mention, let it even be that they explain the effect on the cytric acid cycle, the biochemical proces that facilitates the production of energy in the mitochondria.
The role of the citric acid cycle I have earlier described in my thread Dimethylfumarates and Psoriasis, which is based on an article in the Dutch Magazine of Integral Medicine and written by my doctor.
The observed side effects of MEF (a possible detoriation of the kidney function) is based on the same disadvantage that DMF has to a much lesser extent, that is the negative influence on the mitochondria. It is well known that damaging the mitochondrial function in the first place influences the heart, but in the second place the kidneys. This follows in that chronic kidney diseases are mainly based on damaged mitochondria. This is the reason that chronic kidney diseases nowadays are treated with anti oxidants, for example Cysteine ( Bill ! ) , glutamine and glycine (J Nephrol 2015;42:318-319). MMF seen from this point could be a miracle medicine against heart muscle degradation and kidney degradation, but… also MMF has its lesser sides as it remains immunosuppressive.
By the way, the unwanted side effects of DMF (damaging the mitochondria) can be prevented by eating glutathione rich food and to avoid food with a lot of oxidants. Glutathion is available in raw vegetables and fruit, e.g. Asparagus, avocado and walnuts, fish and meat. You could also use a food supplement wich supplies you with glutathione 250-750 mg per day, depending on your DMF dose.
Schweckendiek prescibed (1981) with the use of fumarates, the anti oxidants cystine and glycine and extensively discussed the mitochondrial functioning in combination with the fumarate treatment.
It can be assumed that the dermatologists are too less aware of what is happening in the body. They may be too busy with the outside. The doctors who show the relation between psoriasis, mitochondria, the citric acid cycle and nutrition are not taken seriously.
The dermatologists are not aware what is happening and keep tight to therapies with MEF included. We do not know the effects of the biologicals on the mitochondria yet, but lets not be too negative on that. There is no research findable on that subject.
While neuro scientists have observed that MMF reduces the damage to the neurons with diseases as MS, Parkinson and other neurodegenerative diseases, in England a RCT has been started with Parkinson patients. The purpose is to stop the progress of this disease by this approach, the past has shown that giving anti oxidants to Parkinson patients is of no use.
We must be aware that the use of immunosuppressive medication increases the chance of dangerous infections, although we have seen in the last more than 30 years that this chance is low with the use of fumarates.
If you would want to lower your microbial “load” in order to reduce other immunosuppressive medication than there is another solution for that.
Literature.
Metabolite of oral DMF drug for multiple sclerosis appears to slow onset of Parkinson's disease; Medical Science News, June 9, 2016